Real-world patterns and predictors of first-line maintenance use among patients with newly diagnosed advanced ovarian cancer: Is there an opportunity for change?

被引：0
|
作者：
Liu, Jinan
Thaker, Premal H.
Sah, Janvi
Maiese, Eric M.
Bee, Oscar
Hurteau, Jean
Chan, John
机构：
[1] GlaxoSmithKline, Navy Yard, PA USA
[2] Washington Univ, Sch Med, St Louis, MO USA
[3] STATinMED, Ann Arbor, MI USA
[4] GlaxoSmithKline, Waltham, MA USA
[5] Sutter Hlth, Div Gynecol Oncol, San Francisco, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.e18710
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18710
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Real-world patterns and predictors of first-line maintenance use among patients with newly diagnosed advanced ovarian cancer: Is there an opportunity for change?
    Liu, Jinan
    Thaker, Premal H.
    Sah, Janvi
    Maiese, Eric M.
    Bee, Oscar
    Hurteau, Jean
    Chan, John
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (28)
  • [2] Starting dose of niraparib as first-line maintenance among patients with newly diagnosed advanced ovarian cancer in a real-world database
    Liu, Jinan
    Thaker, Premal
    Song, Jinlin
    Kalilani, Linda
    Guo, Helen
    Wu, Eric
    Hurteau, Jean
    Chan, John
    GYNECOLOGIC ONCOLOGY, 2022, 166 : S180 - S180
  • [3] Reasons for first-line maintenance therapy discontinuation among patients with newly diagnosed advanced ovarian cancer treated in real-world settings
    Liu, Jinan
    Thaker, Premal H.
    Sah, Janvi
    Maiese, Eric M.
    Kalilani, Linda
    Mallampati, Rajesh
    Hurteau, Jean
    Chan, John
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (28)
  • [4] Poly (adenosine diphosphate [ADP]-ribose) polymerase inhibitor first-line maintenance among patients with newly diagnosed advanced ovarian cancer in a real-world database
    Liu, Jinan
    Chan, John
    Song, Jinlin
    Kalilani, Linda
    Yang, Karen
    Wu, Eric
    Hurteau, Jean
    Thaker, Premal
    GYNECOLOGIC ONCOLOGY, 2022, 166 : S179 - S180
  • [5] Understanding real-world treatment patterns of patients with advanced ovarian cancer in the first-line maintenance setting: The FIRST STEP Study
    Cooney, Maureen
    Kalilani, Linda
    Kiss, Zsofia
    Golembesky, Amanda
    Kobayashi, Monica
    Dayma, Megha
    Coskuncay, Elif
    Schilder, Jeanne
    GYNECOLOGIC ONCOLOGY, 2024, 190 : S202 - S203
  • [6] RENI-1: a prospective, multicenter real-world study of niraparib as first-line maintenance therapy in newly diagnosed advanced ovarian cancer
    Zuo, Jing
    Wang, Ke
    Cui, Zhumei
    Li, Qingshui
    Cheng, Xiaodong
    Zheng, Zhong
    Sun, Lixin
    Zhang, Hui
    Zhang, Jun
    Wang, Shuhe
    Cao, Dongyan
    Chen, Lihong
    Zhao, Hongqin
    Duan, Wei
    Zheng, Min
    Shou, Huafeng
    Li, Jin
    Wang, Yue
    Chen, Xiaoxiang
    Wu, Lingying
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_1) : A315 - A315
  • [7] Real-world prescribing patterns for first-line and maintenance treatment of patients with advanced urothelial cancer (UC)
    Inderjeeth, Andrisha-Jade
    O'haire, Sophie
    Gibbs, Peter
    Wong, Lih-Ming
    Zhang, Alison
    Manohar, Paul
    James, Lynam
    Sengupta, Shomik
    Wong, Shirley
    Weickhardt, Andrew
    Tran, Ben
    Conduit, Ciara
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2023, 19 : 95 - 95
  • [8] FIRST-LINE MAINTENANCE AMONG ADVANCED OVARIAN CANCER PATIENTS IN THE US ONCOLOGY NETWORK: A REAL-WORLD RETROSPECTIVE COHORT STUDY
    Chase, Dana
    Liu, Jinan
    Moore-Schiltz, Laura
    Perhanidis, Jennifer
    Bulsara, Purva
    Patton, Gregory
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2022, 32 : A33 - A33
  • [9] Real-world outcomes of first-line maintenance with niraparib or bevacizumab in advanced ovarian cancer.
    Vasudevan, Anupama
    English, Sandy
    Gart, Mike
    Oladipo, Taofikat
    Hartman, John
    Iadeluca, Laura L.
    Kudrik, Fred J.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [10] Real-world treatment of niraparib as maintenance therapy in patients newly diagnosed advanced ovarian cancer in Japan
    Shimada, Muneaki
    Kuwahara, Yuki
    Kuwabara, Hiroyo
    Kato, Ai
    Tabata, Tsutomu
    ANNALS OF ONCOLOGY, 2023, 34 : S1440 - S1440
12345